BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 29498933)

  • 41. [In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization].
    Ellenbogen A; Atamny R; Fainaru O; Meidan E; Rotfarb N; Michaeli M
    Harefuah; 2011 Nov; 150(11):833-6, 876. PubMed ID: 22428202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
    Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
    Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
    Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
    Eur Rev Med Pharmacol Sci; 2011 May; 15(5):509-14. PubMed ID: 21744744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application value of tumor necrosis factor inhibitors in in vitro fertilization-embryo transfer in infertile women with polycystic ovary syndrome.
    Liang JX; Zhang Y; Xiao CH; Cao S; Tian Y; Wang NN; Liu C
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):247. PubMed ID: 37055769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study.
    Yaylalı A; Bakacak M; Bakacak Z
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):102006. PubMed ID: 33242676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.
    Caprio F; D'Eufemia MD; Trotta C; Campitiello MR; Ianniello R; Mele D; Colacurci N
    J Ovarian Res; 2015 Jun; 8():37. PubMed ID: 26067283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
    Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
    Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
    An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I; Bayar U; Bozdag G; Yarali H
    Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A; Laganà AS; Barbaro L
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.
    Kjøtrød SB; von Düring V; Carlsen SM
    Hum Reprod; 2004 Jun; 19(6):1315-22. PubMed ID: 15117902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of follicle-stimulating hormone priming and nonpriming in in vitro maturation of oocytes in infertile women with polycystic ovarian syndrome: a single-blinded randomized study.
    Choavaratana R; Thanaboonyawat I; Laokirkkiat P; Prechapanich J; Suksompong S; Mekemaharn O; Petyim S
    Gynecol Obstet Invest; 2015; 79(3):153-9. PubMed ID: 25503808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of myo-inositol plus folic acid on ovarian morphology and oocyte quality in PCOS mouse model.
    Haghighi M; Mehdizadeh M; Amjadi F; Zandieh Z; Najafi M; Artimani T; Mohammadi F; Mehdizadeh R
    Zygote; 2023 Apr; 31(2):111-122. PubMed ID: 36617989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial.
    Agrawal A; Mahey R; Kachhawa G; Khadgawat R; Vanamail P; Kriplani A
    Gynecol Endocrinol; 2019 Jun; 35(6):511-514. PubMed ID: 30614289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of FT500 Plus(®) on ovarian stimulation in PCOS women.
    Alviggi C; Cariati F; Conforti A; De Rosa P; Vallone R; Strina I; Pivonello R; De Placido G
    Reprod Toxicol; 2016 Jan; 59():40-4. PubMed ID: 26545973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
    Kdous M; Chaker A; Zhioua A; Zhioua F
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.